ETFs Genmab A/S Nasdaq

GMAB

US3723032062

Biotechnology & Medical Research

Market Closed - Nasdaq 01:30:00 17/10/2026 am IST			5-day change	1st Jan Change
37.00 ^USD	-2.17%		-0.19%	+20.13%

16/10	Nordic stocks in North America - Ericsson rose 2.6 percent	FW
15/10	Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug	RE

ETFs positioned on Genmab A/S

Name	YTD change	Weight	AuM
DIMENSIONAL WORLD EQUITY ETF - USD	+12.45%	-	1,674 M€
DIMENSIONAL INTERNATIONAL SUSTAINABILITY CORE 1 ETF - USD	+5.64%	-	1,193 M€
TEMA ONCOLOGY ETF - USD	+14.19%	3.93%	207 M€
FIRST TRUST NYSE ARCA BIOTECHNOLOGY INDEX FUND ETF - USD	+27.64%	2.87%	2,809 M€
FIRST TRUST NYSE ARCA BIOTECHNOLOGY UCITS ETF - ACC - USD	+27.24%	2.86%	16 M€
ISHARES BIOTECHNOLOGY ETF - USD	+19.68%	1.23%	9,953 M€
WISDOMTREE BIOREVOLUTION UCITS ETF ACC USD	+37.60%	1.07%	24 M€
FIRST TRUST NASDAQ BUYWRITE INCOME ETF - USD	+5.43%	0.23%	949 M€
INVESCO NASDAQ BIOTECHNOLOGY ETF - USD	+18.73%	0.14%	81 M€
ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF (D) - USD	+19.96%	0.13%	78 M€
ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF - USD	+20.43%	0.13%	1,079 M€
FIDELITY ENHANCED INTERNATIONAL ETF - USD	+8.56%	0.1%	11,331 M€
AVANTIS INTERNATIONAL EQUITY ETF - USD	+9.41%	0.09%	18,816 M€
AVANTIS RESPONSIBLE INTERNATIONAL EQUITY ETF - USD	+6.53%	0.06%	361 M€
LEUTHOLD CORE ETF - USD	+5.58%	0.04%	68 M€
AVANTIS INTERNATIONAL LARGE CAP VALUE ETF - USD	+12.61%	0.04%	2,052 M€
FIDELITY SUSTAINABLE WORLD ETF	+17.20%	0.02%	387 M€
FIDELITY NASDAQ COMPOSITE INDEX ETF - USD	+12.70%	0%	10,846 M€
ALPHA ARCHITECT US EQUITY 2 ETF - USD	+10.77%	0%	513 M€
CAMBRIA US EW ETF - USD	+9.73%	0%	194 M€

Genmab A/S specializes in the research and development of human and therapeutic antibodies intended for treating cancers, infectious diseases, rheumatoid arthritis, etc. Net sales break down by type of income as follows: - royalties (83.4%); - income from sales of products (10.7%); - other (5.9%): primarily income from partnership agreement. Net sales are distributed geographically as follows: Denmark (89.4%), the United States (4.9%) and Japan (5.7%).

Employees

3,119

Sector

Biotechnology & Medical Research

Calendar

05/11 Earnings release - Q3 2026

More about the company